Spasticity Market to Surpass USD 3.2 Billion by 2035, Driven by Neurological Disorder Treatments | TMR Analysis
This massive market share is mainly driven by the rising use of Gabapentin for treating spasticity as well as their better clinical outcomes WILMINGTON, DE, UNITED STATES, August 28, 2025 /EINPresswire.com/ -- The global spasticity market, valued at USD …